about
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Enga...
Read More
2.06
-0.02
(-0.96%)
61,232
XNAS Volume
High volume today
XNAS 17 Sep, 2025 1:25 PM (EDT)
Board Meeting
The board meeting for Innate Pharma - ADR is scheduled for today, for the purpose of Innate Pharma SA Second Quarter Earnings Result for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Innate Pharma ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..